Overview
What is Society For Translational Oncology?
The Society for Translational Oncology (STO) is a 501(C)(3) nonprofit organization committed to bridging the gap between drug discovery and approved drug delivery in the field of oncology. Located in Durham, North Carolina, STO focuses on promoting education for oncologists, including medical, radiation, and surgical specialists, as well as nurses, researchers, and other health professionals. Their educational initiatives aim to enhance competencies in screening, prevention, diagnosis, treatment, and management of cancer patients, thereby improving patient care. STO achieves this through various mediums such as live conferences, workshops, internet webcasts, and journal-based articles. Additionally, STO supports the prevention and treatment of infectious diseases that impact cancer patients and those with weakened immune systems during pandemics, such as COVID-19. Their portfolio includes fellowships in both cancer and infectious diseases, demonstrating their long-term commitment to translational research and education. STO has a team of 4 employees dedicated to this mission.
Official website here: www.sto-online.org
Is Society For Translational Oncology legitimate?
Society For Translational Oncology is a legitimate nonprofit organization registered as a 501(c)(3) entity. Society For Translational Oncology submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $128,972
For more financial information, click here
Official website here: www.sto-online.org
What is the mission statement of Society For Translational Oncology?
The Society for Translational Oncology (STO) is a non-profit organization committed to bridging the gap between drug discovery and approved drug delivery in oncology. Its primary mission is to foster the translation of significant new therapies that enhance global oncology practice and support the prevention and treatment of infectious diseases that impact cancer patients with weakened immune systems. STO achieves this by providing a portfolio of educational activities for physicians, aimed at improving patient outcomes. The organization's efforts in translational research and education span over several decades and include fellowships in both cancer and infectious diseases, with the latter becoming a critical focus during the COVID-19 pandemic. Through live conferences, workshops, internet webcasts, and journal-based articles, STO disseminates educational content primarily to medical, radiation, and surgical oncologists, nurses, researchers, and other health professionals, with the goal of improving their competencies and strategies for screening, prevention, diagnosis, treatment, and management of patients with cancer.
Official website here: www.sto-online.org
Who is the CEO of Society For Translational Oncology?
David Jessen is the Executive Director of Society For Translational Oncology.
Official website here: www.sto-online.org
What is the revenue of Society For Translational Oncology?
Society For Translational Oncology's revenue in 2022 was $1,410,812.
Official website here: www.sto-online.org
Who are the executives of Society For Translational Oncology and what are their salaries?
The average compensation at Society For Translational Oncology during 2022 was $32,243. There are 4 employees and 47 volunteers at Society For Translational Oncology.
Here are 7 key members and their salaries:
- Ann Murphy Phd (Executive Director)
- Martin J Murphy Dmedsc Phd Fasco (Chairman) [Trustee/Director]
- David Jessen Cpa (Trasurer) [Trustee/Director]
- Sean Khozin Md Mph (Director)
- Ke Liu Md Phd (Director)
- Mace L Rothenberg Md Facp (Director)
- Lillian L Siu Md Frcpc Fasco (Director)
Official website here: www.sto-online.org
Where can I find the form 990 for Society For Translational Oncology?
The Society For Translational Oncology’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.sto-online.org
Learn more at the official website: www.sto-online.org
Mission Statement of Society For Translational Oncology
The Society for Translational Oncology, a 501(c)(3) nonprofit organization, is dedicated to fostering the discovery and clinical translation of novel therapies in the field of oncology. Its mission is to bridge the translational gap between drug discovery and approved drug delivery, ultimately aiming to enhance the practice of global oncology. To achieve this, the organization provides a portfolio of educational activities for physicians, aiming to improve patient outcomes.
The Society for Translational Oncology's educational interventions are founded on the improvement of physicians' competencies and the development of strategies for screening, prevention, diagnosis, treatment, and management of cancer patients. The organization focuses on medical, radiation, and surgical oncology, disseminating educational content through live conferences, workshops, internet webcasts, and journal-based articles. The audience of the Society for Translational Oncology includes medical, radiation, and surgical oncologists, nurses, researchers, and other health professionals.
In addition to its commitment to translational research and education in oncology, the Society for Translational Oncology has also extended its focus to supporting the prevention and treatment of infectious diseases that impact cancer patients and others with weakened immune systems. This commitment has become particularly critical during the COVID-19 pandemic, contributing to the global genesis and worldwide distribution of new vaccines and improved therapeutics.
Impact
This information is meant to be a general summary of Society For Translational Oncology. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
The Society for Translational Oncology (STO) plays a crucial role in promoting the education of oncologists and other cancer caregivers. By providing publications, meetings, and enduring materials, STO works to bridge the "translational gap" between the discovery of new cancer treatments and their actual deployment to enhance patient care. Through its educational interventions, STO aims to improve physician competencies in screening, prevention, diagnosis, treatment, and management of cancer patients, ultimately enhancing the quality and safety of cancer care.
One of STO's impactful initiatives is the Global Harmonization of Cancer Trials, which is a multi-year guided effort to support the development of novel strategies for improved cancer treatment and prevention. This initiative aims to establish common standards and best practices across different regions to facilitate the seamless development of cancer therapies. By encouraging harmonization among regulatory practices in regions such as the United States, European Union, China, and Africa, STO is driving advancements in cancer research and treatment on a global scale.
Additionally, STO's dedication to translational research and education extends to the prevention and treatment of infectious diseases that impact cancer patients and individuals with weakened immune systems. Particularly highlighted during the COVID-19 pandemic, STO has played a critical role in supporting the global distribution of vaccines and therapeutics to protect vulnerable populations from life-threatening infections.
In summary, the Society for Translational Oncology's commitment to education, research, and global collaboration has a significant impact on advancing cancer care, improving patient outcomes, and addressing the complex challenges in oncology and infectious diseases.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Organization Details
Founding Year
2000
Phone
(919) 433-0489
Principal Officer
David Jessen
Main Address
PO BOX 12412, DURHAM, NC, 27709
Website
www.sto-online.org
NTEE Category
Code: H30 - Medical research
If you are a representative of Society For Translational Oncology and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.